Search

Your search keyword '"Lantz, O."' showing total 370 results

Search Constraints

Start Over You searched for: Author "Lantz, O." Remove constraint Author: "Lantz, O."
370 results on '"Lantz, O."'

Search Results

4. 5MO Hypomethylation of circulating retrotransposons: Towards a non-invasive pan-cancer diagnosis

7. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

9. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

13. 63MO TG4001 therapeutic vaccination combined with PD-L1 blocker avelumab remodels the tumor microenvironement (TME) and drives antitumor responses in human papillomavirus (HPV)+ malignancies

15. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

16. Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity

18. Associations entre profils metabolomiques plasmatiques rmn et composition du microbiote intestinal au sein d’une population d’adultes français en bonne santé

19. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

20. Persistence of donor-specific IL-2-secreting cells and cytotoxic T lymphocyte precursors in human kidney transplant recipients evidenced by limiting dilution analysis

22. Guidelines for the use of flow cytometry and cell sorting in immunological studies

24. Complementarity and redundancy of IL-22-producing innate lymphoid cells

25. Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease

26. Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer

27. UM Cure 2020 - A consortium of European experts in uveal melanoma to identify new therapies for patients with metastatic disease

30. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients

35. Pre-transplant donor CD4−invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease

38. Acute rejection in the absence of cognate recognition of allograft by T cells.

39. 67 POSTER A relevant panel of human uveal melanoma xenografts directly established from primary and/or metastatic patient's tumor for pharmacological preclinical assays

42. Prophylactic Use of the Anti-il-2 Receptor Monoclonal-antibody Lo-tact-1 in Cadaveric Renal-transplantation - Results of a Randomized Study

43. [Treatment With Lo-tact-1, a Monoclonal-antibody To the Interleukin-2 Receptor, in Renal-transplantation]

Catalog

Books, media, physical & digital resources